Judith M. Matthews
2021
In 2021, Judith M. Matthews earned a total compensation of $4.2M as Chief Financial Officer at Iterum Therapeutics plc.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $100,120 |
| Option Awards | $3,388,000 |
| Salary | $381,410 |
| Stock Awards | $320,000 |
| Other | $2,315 |
| Total | $4,241,845 |
Matthews received $3.4M in option awards, accounting for 80% of the total pay in 2021.
Matthews also received $50K in bonus, $100.1K in non-equity incentive plan, $381.4K in salary, $320K in stock awards and $2.3K in other compensation.
Rankings
In 2021, Judith M. Matthews' compensation ranked 3,136th out of 12,415 executives tracked by ExecPay. In other words, Matthews earned more than 74.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,136 out of 12,415 | 75th |
Division Manufacturing | 1,264 out of 5,508 | 77th |
Major group Chemicals And Allied Products | 514 out of 2,378 | 78th |
Industry group Drugs | 455 out of 2,099 | 78th |
Industry Pharmaceutical Preparations | 313 out of 1,549 | 80th |
Source: SEC filing on March 16, 2023.
Matthews' colleagues
We found two more compensation records of executives who worked with Judith M. Matthews at Iterum Therapeutics plc in 2021.